Patents by Inventor Steven J. Karel

Steven J. Karel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110020336
    Abstract: The present invention encompasses a therapeutic combination composition of a ?-glucan EGF receptor antagonist. This therapeutic combination composition is useful for the treatment of diseases including proliferative disorders and immune dysfunction.
    Type: Application
    Filed: October 1, 2010
    Publication date: January 27, 2011
    Inventor: Steven J. Karel
  • Publication number: 20090214562
    Abstract: The present invention encompasses a therapeutic combination composition of a ?-glucan EGF receptor antagonist. This therapeutic combination composition is useful for the treatment of diseases including proliferative disorders and immune dysfunction.
    Type: Application
    Filed: May 2, 2006
    Publication date: August 27, 2009
    Inventor: Steven J. Karel
  • Publication number: 20090169557
    Abstract: The present invention relates to compositions and methods of using whole glucan particles and agents. Whole glucan particles enhance the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. This binding enhances innate immune system cytotoxicity, as well as stimulating the release of activating cytokines and enhances the bodies response to the agent.
    Type: Application
    Filed: May 10, 2005
    Publication date: July 2, 2009
    Inventors: Gordon D. Ross, Trunetta Jo Dockter Ross, Steven J. Karel, Daniel K. Connors, Bill Kournikakis